Real World Treatment of Multiple Sclerosis (MS)

Neurology
Curriculum:
Real World Treatment of Multiple Sclerosis (MS)
Credits:
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s)™
Launch Date:
November 20, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Neurologists, multiple sclerosis (MS) specialists, nurses, and other health care professionals involved in the treatment of patients with MS.

Relevant Terms:

Multiple sclerosis, disease-modifyiing treatments

Robert Bermel, MD

Robert Bermel, MD
Staff Neurologist
Medical Director
Mellen Center for Multiple Sclerosis
Cleveland Clinic
Cleveland, OH

Robert Bermel, MD is staff neurologist and medical director of the Mellen Center for Multiple Sclerosis at Cleveland Clinic. He received a medical degree with thesis honors from the State University of New York at Buffalo, where his interest in multiple sclerosis began while training under Dr. Lawrence Jacobs. Dr. Bermel completed neurology residency training and served as chief resident at Cleveland Clinic. He was funded as a National MS Society postdoctoral fellow in clinical neuroimmunology and advanced imaging at Cleveland Clinic.
 
Dr. Bermel cares for patients, conducts imaging research, and participates in clinical trials at the Mellen Center. His current research interests focus on the identification of advanced imaging methods to evaluate and improve recovery from inflammatory demyelinating disease. Specifically, he is utilizing techniques, such as optical coherence tomography (OCT), diffusion tensor imaging MRI (DTI), and functional MRI (fMRI). In collaboration with Cleveland Clinic ophthalmology, Dr. Bermel directs the digital OCT reading center (DOCTR), a regulatory-compliant central reading center for neurology trials using OCT as an outcome measure. He is currently principal investigator on a research grant funded by the National MS Society, and a co-investigator on multiple clinical trials. Dr. Bermel has published in multiple peer-reviewed journals including Neurology, Annals of Neurology, Archives of Neurology, Lancet Neurology, Journal of Neuroimaging, and others. In 2012, Dr. Bermel organized the first multinational meeting on disease free status as a clinical goal in MS. He is a member of the annual meeting program committee for the American Society of Neuroimaging, the fellowship grant review committee of the National MS Society, and serves as an ad hoc reviewer for multiple scholarly journals. He regularly presents his ongoing work at international conferences.

Patricia K. Coyle, MD, FAAN

Patricia K. Coyle, MD, FAAN
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director
Multiple Sclerosis Comprehensive Care Center at Stony Brook University Medical Center
Stony Brook, NY

Patricia K. Coyle, MD, FAAN, is professor and vice chair (clinical affairs) of neurology, and director of the Multiple Sclerosis Comprehensive Care Center at the Stony Brook University Medical Center in Stony Brook, NY. She received a BS with highest honors from Fordham University in the Bronx, NY, and an MD from The Johns Hopkins School of Medicine, where she was elected to Alpha Omega Alpha. While at the Johns Hopkins, she completed a residency and chief residency in neurology, followed by a 2-year fellowship in neuroimmunology and neurovirology. She then went on to establish a successful research laboratory and build a busy clinical practice at the Stony Brook University Medical Center.
 
Dr. Coyle is the author of numerous articles on clinical and basic research aspects of multiple sclerosis and neurologic infections and is recognized as a leading expert in the field. Her areas of expertise include Lyme disease and neurologic infections, cerebrospinal fluid, therapeutics, and neuroimmunology. Her research has been supported by the National Institutes of Health and other organizations. She is currently involved in a number of therapeutic trials testing new immunotherapies for MS, as well as studies addressing neurologic aspects of Lyme disease. In addition to her busy clinical and research careers, she has held active leadership positions in a number of national and international organizations and academic societies, including the American Academy of Neurology, American Neurological Association, National MS Society, and the American Board of Psychiatry and Neurology. She lectures widely on MS and neurologic infections to national and international audiences.

Megan Weigel, DNP, ARNP-C, MSCN

Megan Weigel, DNP, ARNP-C, MSCN
Advanced Registered Nurse Practitioner
Baptist Neurology Beaches Division
Jacksonville Beach, FL

Megan Weigel, DNP, ARNP-c, MSCN is an advanced registered nurse practitioner who has been practicing neurology for 13 years and has been a Multiple Sclerosis Certified Nurse (MSCN) for 8 years. She currently works at Baptist Neurology, Beaches Division, where she specializes in the care of patients with multiple sclerosis (MS). She received her Doctor of Nursing Practice degree from the University of Florida in 2009, with a research focus on preventive health care in patients with MS. Dr. Weigel was chosen as one of Jacksonville’s “40 Under 40” by the Jacksonville Business Journal in 2010, and received an Outstanding Young Alumnus award from the University of Florida in 2010. She served 2 terms on the Board of Directors for the International Organization of MS Nurses. She is a member of the North Florida chapter of the National MS Society’s Clinical Advisory Committee, acts as their research advocate, and is an active fundraiser. Dr. Weigel speaks nationally to patients and health care providers on topics related to the care of people living with MS. As a registered yoga teacher, she is the cofounder of OMS Yoga, a program that has brought free yoga to people living with MS in the Jacksonville area.
1. Implement the early use of disease-modifying treatments to slow multiple sclerosis progression, reduce long-term disability, and preserve quality of life. (Physicians)
2. Evaluate the early use of disease-modifying treatments to slow multiple sclerosis progression, reduce long-term disability, and preserve quality of life. (Nurses)
3. Evaluate the efficacy and safety profiles of disease-modifying therapies to enable tailoring of long-term treatment for the best possible outcomes. (Physicians and Nurses)
4. Develop collaborative strategies to improve quality of care and reinforce adherence to multiple sclerosis treatment. (Physicians and Nurses)

Provider
This continuing medical education activity is provided by Vindico Medical Education.
 
Supporter
This activity is supported by an educational grant from Teva Pharmaceuticals.
 
There is no non-commercial support for this activity.
 
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
 
Target Audience
The intended audience for this activity is neurologists, multiple sclerosis (MS) specialists, nurses, and other health care professionals involved in the treatment of patients with MS.
 
Purpose/Learning Objectives
Upon successful completion of the CME activity, physicians will be better able to:
  • Implement the early use of disease-modifying treatments to slow multiple sclerosis progression, reduce long-term disability, and preserve quality of life.
  • Evaluate the efficacy and safety profiles of disease-modifying therapies to enable tailoring of long-term treatment for the best possible outcomes.
  • Develop collaborative strategies to improve quality of care and reinforce adherence to multiple sclerosis treatment.
Upon successful completion of the CNE activity, nurses will be better able to:
  • Evaluate the early use of disease-modifying treatments to slow multiple sclerosis progression, reduce long-term disability, and preserve quality of life.
  • Evaluate the efficacy and safety profiles of disease-modifying therapies to enable tailoring of long-term treatment for the best possible outcomes.
  • Develop collaborative strategies to improve quality of care and reinforce adherence to multiple sclerosis treatment.
External Reviewer
Aaron Miller, MD
 
Nurse Planner
Amy Perrin Ross, APN, MSN, CNRN, MSCN
 
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
 
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Vindico Medical Education will provide 1 contact hours for nurses.
 
This enduring material is approved for 1 year from the date of original release, November 20th, 2015 to November 20th, 2016.
 
How To Participate in this Activity and Obtain CME/CNE Credit:
To participate in this CME/CNE activity, you must read the objectives, answer the pretest questions, review the CME/CNE Content, complete the CME/CNE posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or Learner-Paced Contact Hours Certificate.
 
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
 
Planning Committee and Faculty members report the following relationship(s):
Robert Bermel, MD
Consulting Fee: Biogen Idec., Genentech, Genzyme, Novartis
 
Patricia K. Coyle, MD, FAAN
Consulting Fee: AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, Teva Pharmaceuticals
Contracted Research: Actelion, Novartis, Opexa
 
Megan Weigel, DNP, ARNP-C, MSCN
Consulting Fee: Biogen, Genentech, Genzyme, Mallinckrodt
Speakers Bureau: Acorda, EMD Serono, Inc., Genzyme, Mallinckrodt, Novartis, Pfizer, Teva Pharmaceuticals
 
Reviewers report the following relationship(s):
Aaron Miller, MD
Consulting Fee: Acorda, Accordant, Alkermes, Biogen Idec, CareMark (Accordant Health Care), EMD Serono (Merck Serono), Genentech, Genzyme/Sanofi-Aventis, GlaxoSmithKline, Mallinckrodt (Questcor), Novartis, Roche, Teva Pharmaceuticals
Contracted Research: Biogen Idec, Genentech, Genzyme, Mallinckrodt (Questcor), Novartis, Roche
Sanofi-Aventis
Speakers Bureau: Biogen Idec
 
Ronald A. Codario, MD, FACP, FNLA, CCMEP
No relevant financial relationships to disclose.
 
Nurse Planners report the following relationship(s):
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Consulting Fee: Acorda, Bayer, EMD Serono, Genzyme, Genentech, Mallinckrodt, Novartis, Teva Pharmaceuticals
Speakers Bureau: Acorda, Bayer, EMD Serono, Genzyme, Novartis, Mallinckrodt, Teva Pharmaceuticals
 
Barbara L. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
 
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
 
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
 
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
 
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
 
CME Questions?
Contact us at cme@vindicomeded.com
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above